Pneumococcal Vaccines Industry Pneumococcal Vaccines Industry

2017 Global Pneumococcal Vaccines Industry Size, Share, Growth,
Analysis & Market Demand- Planet Market Reports
In this report, the Global Pneumococcal Vaccines Market is valued at USD XX million in 2016
and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX%
between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales K Units, revenue
Million USD, market share and growth rate of Pneumococcal Vaccines for these regions, from
2012 to 2022 forecast, covering
• United States
• China
• Europe
• Japan
• Southeast Asia
• India
Global Pneumococcal Vaccines market competition by top manufacturers/players, with
Pneumococcal Vaccines sales volume, Price USD/Unit, revenue Million USD and market
share for each manufacturer/player; the top players including
• Pfizer
• Sanofi
• GSK
• Merck
• Eli Lilly
• AstraZeneca
• Abera
• S K Chemicals
• Beijing Minhai Biotechnology
• Baxter
• Biken
• Celgene Corporation
• Panacea Biotec
• Serum Institute of India
• Genentech
• Genocea Biosciences
• ImmunoBiology
• Lupin
• Nuron Biotech